The present invention relates to processes, arrangements, computer-accessible medium and systems which can provide a fiber layer thickness map based on optical coherence tomography (“OCT”) images, and more particularly to such processes, systems, computer-accessible medium and arrangements that the boundaries and therefore the thickness of a layer in the sample can be automatically determined starting from OCT images.
Spectral-domain optical coherence tomography (“SD-OCT”) was recently established as a real-time technique for investigating the depth structure of biomedical tissue with the purpose of non-invasive optical diagnostics. A detailed description of SD-OCT techniques is described in Fercher et al. “Measurement of Intraocular Distances by Backscattering Spectral Interferometry”, Optics Communications, 117(1-2), 43 (1995) and Wojtkowski et al. “In vivo human retinal imaging by Fourier domain optical coherence tomography”, J. Biomed. Opt. 7(3), 457 (2002). Compared to the commercially available time-domain OCT systems, SD-OCT techniques provide for video-rate OCT scans, are relative fast, as shown in Nassif et al. “In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography”, Opt. Lett. 29(5), 480 (2004), and provide a good sensitivity, as described in Leitgeb et al. “Performance of Fourier domain vs. time domain optical coherence tomography”, Opt. Express, 11(8), 889 (2003) and de Boer et al. “Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography”, Opt. Lett., 28(21), 2067 (2003). An exemplary arrangement which can be used for video-rate OCT scans has been described in International application number PCT/US03/02349 filed Jan. 24, 2003 and in Nassif et al. “In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography”, Opt. Lett., 29(5), 480 (2004).
Similar technology, e.g., Optical Frequency Domain Imaging (“OFDI”), can use a rapidly tuned laser to measure the wavelength resolved interference as described in Chinn et al. “Optical coherence tomography using a frequency tunable optical source”, Opt. Lett. 22(5), 340 (1997), and Yun et al. “High-speed optical frequency-domain imaging”, Opt. Express 11(22), 2953 (2003) and International Application PCT/US04/029148 filed Sep. 8, 2004.
The depth profile in SD-OCT/OFDI can be obtained as the Fourier transform (“FFT”) of the spectral interference in a Michelson interferometer as described in Fercher et al. “Measurement of Intraocular Distances by Backscattering Spectral Interferometry”, Optics Communications, 117(1-2), 43 (1995) and Wojtkowski et al. “In vivo human retinal imaging by Fourier domain optical coherence tomography”, J. Biomed. Opt. 7(3), 457 (2002). The data processing steps to generate a good quality structural SD-OCT image have been described in Cense et al. “Ultrahigh-resolution high-speed retinal imaging using spectral-domain optical coherence tomography”, Opt. Express, 12(11), 2435 (2004), Yun et al. “High-speed optical frequency-domain imaging”, Opt. Express, 11(22), 2953 (2003), and Nassif et al. “In vivo high-resolution video-rate spectral-domain optical coherence tomography of the human retina and optic nerve”, Opt. Express, 12(3), 367 (2004). Various dispersion compensation techniques for OCT have been described in Marks et al. “Autofocus algorithm for dispersion correction in optical coherence tomography”, Appl. Opt., 42(16), 3038 (2003), Marks et al. “Digital algorithm for dispersion correction in optical coherence tomography for homogeneous and stratified media”, Appl. Opt., 42(2), 204 (2003), Wojtkowski et al. “Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation”, Opt. Express, 12(11), 2404 (2004), and Fercher et al. “Numerical dispersion compensation for Partial Coherence Interferometry and Optical Coherence Tomography”, Opt. Express, 9(12), 610 (2001).
In ophthalmic applications, it has been suggested that OCT may be helpful for diagnosing glaucoma by measuring the thickness of the retinal nerve fiber layer (RNFL). In publications, the RNFL thickness has been evaluated with time-domain OCT commercial instruments for only a small number of circular scans, in general three, and not as a full map of the retina. A method to generate a large area thickness map of the RNFL is desirable. See e.g., Bourne et al. “Comparability of retinal nerve fiber layer thickness measurements of optical coherence tomography instruments” Invest. Opthalmol. Visual Sci., 46(4), 1280 (2005), Carpineto et al. “Reliability of nerve fiber layer thickness measurements using optical coherence tomography in normal and glaucomatous eyes” Opthalmology, 110(1), 190 (2003), Aydin et al. “Optical coherence tomography assessment of retinal nerve fiber layer thickness changes after glaucoma surgery”, Opthalmology, 110(8), 1506 (2003), and Guedes et al. “Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes”, Opthalmology, 110(1), 177 (2003).
Additional extensions of OCT techniques such as polarization-sensitive OCT (“PS-OCT”) can assist in identifying the properties of the RNFL including the layer's birefringence and boundaries as described in Cense et al. “In vivo birefringence and thickness measurements of the human retinal nerve fiber layer using polarization-sensitive optical coherence tomography”, J. Biomed. Opt., 9(1), 121 (2004), International Application PCT/US05/39374 filed Oct. 31, 2005, International Application PCT/US07/66017 filed Apr. 5, 2007 and International Application PCT/US06/15484 filed Apr. 24, 2006. It is believed that birefringence changes of the RNFL may preclude thickness changes and therefore, birefringence measurement can assist in early diagnosis of glaucoma.
Boundary detection has been studied since the early days of computer vision and image processing, and different approaches have been proposed. Segmentation procedures have also been applied to retinal imaging either for estimating the thickness of various retinal layers, as presented in Ishikawa et al. “Macular segmentation with optical coherence tomography”, Invest. Opthalmol. Visual Sci., 46(6), 2012 (2005) and Fernandez et al. “Automated detection of retinal layer structures on optical coherence tomography images”, Opt. Express, 13(25), 10200 (2005), or for evaluating the thickness of the retina, as presented in Koozekanani et al. “Retinal thickness measurements from optical coherence tomography using a Markov boundary model”, IEEE Trans. Medical Imag., 20(9), 900 (2001). Another segmentation technique based on a deformable spline (snake) algorithm has been described in details in Xu and Prince, “Snakes, shapes, and gradient vector flow” IEEE Trans. Image Process., 7(3), 359 (1998) and Kass et al. “Snakes—Active Contour Models”, Int. J. Comput. Vis., 1(4), 321 (1987). As the snake seeks to minimize its overall energy, its shape will converge on the image gradient contour. However, in general, the snake may not be allowed to travel extensively, and proper initialization may be needed. The snake parameters (elasticity, rigidity, viscosity, and external force weight) can be set to allow the snake to follow the boundary for a large number of retinal topographies. Deformable spline procedures are widely used in medical imaging.
A RNFL thickness map is a quantitative assessment and provides evaluation of large retinal areas as compared to a limited number of circular or radial scans measured with the current commercial instruments. The RNFL thickness maps can potentially be used for a thorough evaluation of the RNFL thickness in longitudinal studies of glaucoma progression. These procedures use large area RNFL thickness maps, which may allow for more accurate correlations of RNFL thinning with visual field defects as opposed to individual circular or radial scans that should be measured at precisely the same retinal location, which is very difficult and that give less information. Therefore, a methodology that allows a determination of RNFL thickness maps based on noise suppression and edge detection may be desirable. Also an intuitive representation of OCT data may be desirable for diagnostic purposes by correlating the quantitative RNFL thickness map with an ultra-high resolution OCT movie, therefore providing a comprehensive picture to clinicians.
Accordingly, there is a need to overcome the deficiencies as described herein above.
To address and/or overcome the above-described problems and/or deficiencies, exemplary embodiments of processes, systems, computer-accessible medium and arrangements that the boundaries and therefore the thickness of a layer in the sample can be automatically determined starting from OCT images. For example, exemplary processes, systems, computer-accessible medium and arrangements may be provided for determining the thickness of retinal layers including but not limited to the RNFL.
According to one exemplary embodiment of the present invention, it is possible to implement the procedures, systems and arrangements described in U.S. Pat. No. 6,980,299 and International Application No. PCT/US04/023585 filed Jul. 23, 2004
The exemplary embodiments of the procedures, systems, computer-accessible medium and arrangements according to the present invention can be used to identify the boundaries of the retinal layers, such as but not limited to the anterior and posterior RNFL boundaries. In further exemplary embodiments, the retinal layers can by defined and be differentiated based on various characteristics, including but not limited to the magnitude and/or standard deviation of intensity reflectance, polarization properties, texture, and/or Doppler properties.
In addition, the exemplary embodiments of the procedures, systems, computer-accessible medium and arrangements according to the present invention can be used to determine the retinal surface topography and the topography of the optic nerve head (“ONH”). High-resolution characterization of the ONH topography can be interesting for a quantitative assessment of glaucoma. Further, another exemplary embodiment of the procedures, systems and arrangements according to the present invention can be used to determine the boundaries of the retinal pigment epithelium (“RPE”). The shape of the RPE may be interesting in the analysis of retinal drusen. Yet further exemplary embodiments of the procedures, systems, computer-accessible medium and arrangements according to the present invention are capable of quantifying the retinal nerve fiber tissue by measuring the RNFL thickness and the thickness distribution across large areas of the retina.
Thus, according to the exemplary embodiments of the present invention, it is possible to:
Still another exemplary embodiment of the procedures, systems, computer-accessible medium and arrangements according to the present invention are capable of facilitating clinical interpretation of the OCT data. A display modality, as an exemplary embodiment, can combine the thickness map and a reflectivity map (e.g., a fundus-type image), together with the cross-sectional images of the retina (e.g., OCT movie).
In yet another exemplary embodiment of the procedures, systems, computer-accessible medium and arrangements according to the present invention, different images can be combined with their difference and/or ratio to illustrate features not evident from either of the two images. For example, the two images can be 3D volumes, cross-sectional OCT frames and or thickness maps. Such exemplary images may be obtained from measurements taken at different patient visits and the difference between them could indicate changes as a result of disease progression.
According to still further exemplary embodiment of the present invention, the measurement may be performed on the same eye using light from different spectral bands. The scattering/reflectivity/absorption properties of the ocular tissue can depend on the wavelength of light, and therefore, measurements performed within different wavelength bands could potentially reveal different structural and morphological information.
In yet another exemplary embodiment of the present invention, these exemplary images may be different due to, e.g., external stimuli or factors including but not limited to light, medication, or blood pressure, and therefore, the difference or ratio image could reveal functional properties of the ocular tissue.
Thus, according to one exemplary embodiment of the present invention, a system, arrangement, computer-accessible medium and process may be provided for determining information associated with at least one portion of an anatomical structure. For example, an interference between at least one first radiation associated with a radiation directed to the anatomical structure and at least one second radiation associated with a radiation directed to a reference can be detected. Three-dimensional volumetric data can be generated for the at least one portion as a function of the interference. Further, the information can be determined which is at least one geometrical characteristic and/or at least one intensity characteristic of the portion based on the volumetric data.
For example, the first radiation can be generated by a low coherence source, and the interference may be detected simultaneously for separate wavelengths that are different from one another. The first radiation can also be generated by an automatically wavelength-tuned light source. The anatomical structure can be an ocular structure. The geometrical characteristic can include at least one continuous boundary. The generation of the continuous boundary can be based on:
Further, the boundary can define a topological structure, and the information may include a geometry, a curvature, a volume and/or a thickness of the topological structure. It is also possible to generate at least one visualization associated with the information. The visualization can be at least one image. In addition, it is possible to determine at least one change of the information as a function of at least one condition.
According to yet another exemplary embodiment of the present invention, it is possible to filter the three-dimensional volumetric data based on a priori knowledge associated with the anatomical structure, and the information may be determined as a function of the filtered volumetric data. The priori knowledge can be based on at least one characteristic of a system performing such functions. The priori knowledge can also be based on at least one characteristic of a known progression of at least one abnormality associated with the anatomical structure.
In still another exemplary embodiment of the present invention, the first radiation can comprise a first radiation signal provided at a first wavelength range and a second radiation signal provided at a second wavelength range which is different from the first range. The three-dimensional volumetric data may be generated as a function of the first and second radiation signals. The first radiation can further comprise a third radiation signal provided at a third wavelength range which is different from the first and second ranges. Thus, the three-dimensional volumetric data may be generated as a function of the first, second and third radiation signals, and the information can be a color volume of the portion of the anatomical structure.
These and other objects, features and advantages of the present invention will become apparent upon reading the following detailed description of embodiments of the invention, when taken in conjunction with the appended claims.
Further objects, features and advantages of the invention will become apparent from the following detailed description taken in conjunction with the accompanying figures showing illustrative embodiments of the invention, in which:
FIGS. 1A(a) through 1A(l) are exemplary illustrations of images takes during an implementation of an exemplary embodiment of a process for locating, e.g., RNFL boundaries and thickness according to the present invention;
FIGS. 5A(top) and 5B(top) are combined exemplary representations of an integrated reflectance map obtained using the exemplary procedures, systems and arrangements according to the present invention;
FIGS. 5A(bottom) and 5B(bottom) are combined exemplary representations of a RNFL thickness map using the exemplary procedures, systems and arrangements according to the present invention;
Throughout the figures, the same reference numerals and characters, unless otherwise stated, are used to denote like features, elements, components or portions of the illustrated embodiments. Moreover, while the subject invention will now be described in detail with reference to the figures, it is done so in connection with the illustrative embodiments. It is intended that changes and modifications can be made to the described embodiments without departing from the true scope and spirit of the subject invention as defined by the appended claims.
The exemplary embodiments of procedures, systems and arrangements according to the present invention which is configured to process data for determining an RNFL thickness can involve, e.g., certain steps of edge detection. In one such exemplary embodiment, the exemplary process can be performed frame by frame in 2D by identifying the edges corresponding to the anterior and posterior boundaries of the RNFL 1000 as shown in FIG. 1A(b). According to another exemplary embodiment, the analysis can be performed in 3D thereby extending the exemplary embodiment described herein above from being a 2D analysis to a 3D analysis.
Particularly, FIGS. 1A(a) through 1A(l) are exemplary illustrations of images takes during an implementation of an exemplary embodiment of a process for locating, e.g., RNFL boundaries and thickness according to the present invention.
The first step (100) of the exemplary process of
Certain areas in the OCT scan, e.g., around the ONH and the fovea, may contain weak edges that should still to be identified, and such procedure can indicate how low the threshold should be set. Certain false edges are, however, preserved this way due to the noise in the image. They could be eliminated or reduced by removing any object in the binary image that has an area smaller than a certain percentage of the total image size determined based on analyzing a large number of images. The exemplary purpose is to preserve preferably the continuous lines across the image, and therefore this value could be set based on the size of the image. The exemplary result is shown in the image of FIG. 1A(a).
The initial guess for AB 1010 can then be determined as the first unity pixel from the top in the binary edge image along each column (step 100-30 of
This exemplary initial guess of AB 1010 may be used as initialization for a multiresolution deformable spline algorithm/procedure. The external force field for the snake algorithm/procedure may be obtained as the gradient of the edge image that was generated as described above for a Gaussian kernel (step 100-60 of
The anterior boundary of the RNFL 1000 can be used to create and display the 3D topography of the retinal surface and of the ONH. (Step 100-90 of
The second step in determining the RNFL thickness is to identify the posterior boundary (“PB”) 1140 of the nerve fiber layer (step 110 of
Certain exemplary preliminary steps can be taken before the actual estimation of the PB 1140. As an initial matter, everything above the AB 1010 can be removed (step 110-5 of
Further, the image can be processed to generate the smoothed field f (FIG. 1A(c)) and the edge field s (FIG. 1A(d)) by using an algorithm for joint anisotropic smoothing and edge-preservation. (Step 110-10 of
where the notation ∥.∥k represents an lk norm (k=1, 2), and the integration is done over the entire image.
The first term can represent the data fidelity and controls the degree to which the smoothed field f resembles the original image g. The second term, representing the smoothness constraint, may penalize large gradients in f except where edges exist (s 1), generating the greatest anisotropic smoothing far away from the edges. The last two terms, representing the edge penalty, can control the edge width and prevent the minimization process from placing edges everywhere in the edge field s. The real positive scalars α, β, and ρ can adjust the relative weighting between these competing terms. The solution of Eq. (1) may be obtained by iterative minimization of the cost functional until convergence to a predefined tolerance level is achieved or an exemplary maximum number of iterations can be exceeded. The subsequent steps in the image processing may be based on f and s, and preferably not the original image.
In a further exemplary embodiment of the present invention, the original image g in Eq. (1) can be replaced by a model image based on a priori knowledge of the retinal structure. In a normal retina, the structure, the properties, and the number of the layers are known, and a model based extraction of the layers' boundaries can be used. Deviations from the model can indicate pathologies and could help in diagnosing retinal diseases.
An identification of blood vessels 1020 position in the RNFL 1000 can also be beneficial prior to the estimation of the PB 1140. This can be done based on the analysis of the RPE 1030. Scattering and absorption of the OCT beam due to the blood can significantly reduce the ability of the OCT beam to probe behind the blood vessels 1020, and the structural image (FIG. 1A(b)) appears to have a “shadow” underneath the blood vessels 1020. This can generate “holes” 1040 in the PB 1140 as well as in the RPE 1030. The RPE 1030 can be identified in the image, and the index of the A-lines corresponding to these “holes” 1040 can be estimated. These indices, that may be declared as invalid, can later be used in the analysis of the PB 1140.
The identification of the RPE 1030 may be based on both the magnitude of the smoothed field f and its gradient, e.g., the edge field s. An intensity mask (FIG. 1A(e)) may be generated from the smoothed field f based on the statistical properties of f, mean and standard deviation, using mean(f)−std(f) as threshold. (Step 110-15 of
In yet another exemplary embodiment of the present invention, a map of the blood vessels network and the boundaries of the optic disc can be determined from the entire 3D OCT scan rather than frame by frame. After identifying the AB 1010, it is possible to remove from the 3D OCT scan a band below the AB 1010 that may include the RNFL 1000 and then integrate the depth profiles generating a RPE map. Integrating preferably only the layers below the RNFL 1000 can increase the contrast of the RPE map since the RPE 1030 is likely the strongest reflecting layer below the RNFL 1000. Appropriate thresholding and segmentation of the RPE map may provide the invalid A-lines (indices) described above, as well as the boundaries of the optic disc that can be used subsequently for identifying the PB 1140.
The RPE area 1060 can be removed from the smoothed field f, the intensity mask, and the binary edge image, and the rest of the processing is focused on the posterior boundary 1140 of the RNFL 1000. (Step 110-35 of
An initial guess of the PB 1140 can be estimated as the first pixel of value one from the top along each A-line (see white dots 1100 in FIG. 1A(i)). (Step 110-55 of
At this point, the deformable spline algorithm/procedure can be applied. The intensity mask 1050 is applied to the original edge field s, and the edge field is then blurred with a Gaussian kernel. The external forces are calculated as gradient of the rescaled edge field, and they are set to zero for the A-lines with invalid indices. (Step 110-65 of
The exemplary results of the exemplary procedure according to the present invention described above are shown in FIG. 1A(l) by displaying the identified AB 1010 and PB 1140 on the corresponding structural image. The exemplary parameters in the process, system and arrangement according to the exemplary embodiments of the present invention, such as threshold values, snake parameters for anterior and posterior boundaries, and RPE thickness, can be established based on a large number of OCT scans in different areas of the retina and for different subjects to account for a statistically significant variability in the boundaries' characteristics. The snake parameters can be set differently for AB 1010 and PB 1140 given the different properties of the two boundaries. The exemplary data sets described herein can be processed with fixed settings for AB 1010 and PB 1140.
According to another exemplary embodiment of the present invention, as shown in
Previously, a visualization has been demonstrated where a fundus-type image was shown as a still picture simultaneously with the OCT movie—see Jiao et al. “Simultaneous acquisition of sectional and fundus ophthalmic images with spectral-domain optical coherence tomography”, Opt. Express, 13(2) 444 (2005). A line across this picture indicated the position of the OCT scan for orientation along the retinal surface. This picture was obtained by integrating the depth profiles (the reflectance) and was displayed on a logarithmic scale. This operation creates enough contrast to differentiate between the A-lines that correspond to blood vessels' location and those that do not intersect blood vessels. The scattering and absorption on blood reduce the total reflectance in the area corresponding to blood vessels and the vessels appear darker than the surroundings.
According to the exemplary embodiment of the present invention, a smoother image can be obtained by, e.g., integrating the logarithmic depth profile and displaying it in linear scale as shown in the exemplary images on the right sides of
As compared to a fundus image of the same eye (as shown in the left side of
The experimental measurements described herein above were performed on the right eye of a healthy volunteer. According to another exemplary embodiment of the present invention as shown in
In another exemplary embodiment of the present invention
The position of the blood vessels across the cross-sectional images, indicated by their “shadow”, can be correlated with the intersection of the horizontal line with the vasculature evident in the integrated reflectance map. The integrated reflectance map may also illustrate the orientation of the blood vessels with respect to the cross-sectional scans, thus allowing for a clear interpretation of the continuous and sometimes sudden change in the apparent diameter of the blood vessels. The association of the integrated reflectance map and of the RNFL thickness map with the OCT movie can provide the clinicians a more intuitive way of interpreting the OCT data for diagnosing retinal diseases such as glaucoma.
The dark band on the center left side of the RNFL thickness map shown in FIG. 5B(bottom) can correspond to the temporal raphe, a structure located temporal to the macula. Since it may be difficult to distinguish individual fibers, it is also difficult to see the structure and the direction of the retinal nerve fibers in the thickness map. However, the RNFL thickness is small in the raphe area since there are a limited number of fibers. Moving away from the raphe, additional fibers comprise the RNFL and the thickness likely increases. The exemplary RNFL thickness map obtained according to the exemplary embodiments of the present invention may be consistent with the RNFL distribution pattern described in Vrabec “Temporal Raphe of Human Retina”, Am. J. Opthalmol., 62(5), 926 (1966) that was confirmed later on by opthalmoscopy as described in Sakai et al. “Temporal Raphe of the Retinal Nerve-Fiber Layer Revealed by Medullated Fibers”, Jpn. J. Opthalmol., 31(4), 655 (1987).
According to yet a further exemplary embodiment of the present invention, two exemplary RNFL thickness maps 6000, 6010 corresponding to the same scan area on the same eye can be obtained as shown in
In still another exemplary embodiment of the present invention, the measurement can be performed on the same eye using light from different spectral bands. The scattering/reflectivity/absorption properties of the ocular tissue can depend on the wavelength of light, and therefore, measurements performed with different wavelength bands may potentially reveal different structural and morphological information. The exemplary images 6000, 6010 shown in
In still another exemplary embodiment of the present invention, the exemplary 3D OCT scans can be acquired for multiple (e.g., three) different wavelength bands and the structural information obtained in each wavelength band can be mapped to a color system including but not limited to the RGB system. A color volume representation of the OCT data may provide structural and morphological information not otherwise evident.
The above-described exemplary embodiments of the processes and procedures according to the present invention can be performed by processing arrangements described in a number of patent applications referenced herein. For example, one exemplary embodiment of the system/arrangement according to the exemplary embodiment of the present invention which is configured to perform such exemplary processes and/or procedures is shown in
In the exemplary operation of the system/arrangement according to one embodiment of the present invention shown in
The foregoing merely illustrates the principles of the invention. Various modifications and alterations to the described embodiments will be apparent to those skilled in the art in view of the teachings herein. Indeed, the arrangements, systems and methods according to the exemplary embodiments of the present invention can be used with any OCT system, OFDI system, SD-OCT system or other imaging systems, and for example with those described in International Patent Application PCT/US2004/029148, filed Sep. 8, 2004, U.S. patent application Ser. No. 11/266,779, filed Nov. 2, 2005, and U.S. patent application Ser. No. 10/501,276, filed Jul. 9, 2004, the disclosures of which are incorporated by reference herein in their entireties. It will thus be appreciated that those skilled in the art will be able to devise numerous systems, arrangements and methods which, although not explicitly shown or described herein, embody the principles of the invention and are thus within the spirit and scope of the present invention. In addition, to the extent that the prior art knowledge has not been explicitly incorporated by reference herein above, it is explicitly being incorporated herein in its entirety. All publications referenced herein above are incorporated herein by reference in their entireties.
This application is based upon and claims the benefit of priority from U.S. Patent Application Ser. No. 60/800,088, filed May 12, 2006, the entire disclosure of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2339754 | Brace | Jan 1944 | A |
3090753 | Matuszak et al. | May 1963 | A |
3601480 | Randall | Aug 1971 | A |
3856000 | Chikama | Dec 1974 | A |
3872407 | Hughes | Mar 1975 | A |
3941121 | Olinger | Mar 1976 | A |
3973219 | Tang et al. | Aug 1976 | A |
3983507 | Tang et al. | Sep 1976 | A |
4030827 | Delhaye et al. | Jun 1977 | A |
4140364 | Yamashita et al. | Feb 1979 | A |
4141362 | Wurster | Feb 1979 | A |
4224929 | Furihata | Sep 1980 | A |
4295738 | Meltz et al. | Oct 1981 | A |
4300816 | Snitzer et al. | Nov 1981 | A |
4303300 | Pressiat et al. | Dec 1981 | A |
4428643 | Kay | Jan 1984 | A |
4479499 | Alfano | Oct 1984 | A |
4533247 | Epworth | Aug 1985 | A |
4585349 | Gross et al. | Apr 1986 | A |
4601036 | Faxvog et al. | Jul 1986 | A |
4607622 | Fritch et al. | Aug 1986 | A |
4631498 | Cutler | Dec 1986 | A |
4650327 | Ogi | Mar 1987 | A |
4744656 | Moran et al. | May 1988 | A |
4751706 | Rohde et al. | Jun 1988 | A |
4770492 | Levin et al. | Sep 1988 | A |
4827907 | Tashiro et al. | May 1989 | A |
4834111 | Khanna et al. | May 1989 | A |
4868834 | Fox et al. | Sep 1989 | A |
4890901 | Cross, Jr. | Jan 1990 | A |
4892406 | Waters | Jan 1990 | A |
4909631 | Tan et al. | Mar 1990 | A |
4925302 | Cutler | May 1990 | A |
4928005 | Lefevre et al. | May 1990 | A |
4965441 | Picard | Oct 1990 | A |
4965599 | Roddy et al. | Oct 1990 | A |
4993834 | Carlhoff et al. | Feb 1991 | A |
4998972 | Chin et al. | Mar 1991 | A |
5039193 | Snow et al. | Aug 1991 | A |
5040889 | Keane | Aug 1991 | A |
5045936 | Lobb et al. | Sep 1991 | A |
5046501 | Crilly | Sep 1991 | A |
5065331 | Vachon et al. | Nov 1991 | A |
5085496 | Yoshida et al. | Feb 1992 | A |
5120953 | Harris | Jun 1992 | A |
5121983 | Lee | Jun 1992 | A |
5127730 | Brelje et al. | Jul 1992 | A |
5197470 | Helfer et al. | Mar 1993 | A |
5202745 | Sorin et al. | Apr 1993 | A |
5212667 | Tomlinson et al. | May 1993 | A |
5214538 | Lobb | May 1993 | A |
5228001 | Birge et al. | Jul 1993 | A |
5241364 | Kimura et al. | Aug 1993 | A |
5248876 | Kerstens et al. | Sep 1993 | A |
5262644 | Maguire | Nov 1993 | A |
5291885 | Taniji et al. | Mar 1994 | A |
5293872 | Alfano et al. | Mar 1994 | A |
5293873 | Fang | Mar 1994 | A |
5304173 | Kittrell et al. | Apr 1994 | A |
5304810 | Amos | Apr 1994 | A |
5305759 | Kaneko et al. | Apr 1994 | A |
5317389 | Hochberg et al. | May 1994 | A |
5318024 | Kittrell et al. | Jun 1994 | A |
5321501 | Swanson et al. | Jun 1994 | A |
5353790 | Jacques et al. | Oct 1994 | A |
5383467 | Auer et al. | Jan 1995 | A |
5411016 | Kume et al. | May 1995 | A |
5419323 | Kittrell et al. | May 1995 | A |
5439000 | Gunderson et al. | Aug 1995 | A |
5441053 | Lodder et al. | Aug 1995 | A |
5450203 | Penkethman | Sep 1995 | A |
5454807 | Lennox et al. | Oct 1995 | A |
5459325 | Hueton et al. | Oct 1995 | A |
5459570 | Swanson et al. | Oct 1995 | A |
5465147 | Swanson | Nov 1995 | A |
5486701 | Norton et al. | Jan 1996 | A |
5491524 | Hellmuth et al. | Feb 1996 | A |
5491552 | Knuttel | Feb 1996 | A |
5526338 | Hasman et al. | Jun 1996 | A |
5555087 | Miyagawa et al. | Sep 1996 | A |
5562100 | Kittrell et al. | Oct 1996 | A |
5565986 | Knüttel | Oct 1996 | A |
5583342 | Ichie | Dec 1996 | A |
5590660 | MacAulay et al. | Jan 1997 | A |
5600486 | Gal et al. | Feb 1997 | A |
5601087 | Gunderson et al. | Feb 1997 | A |
5621830 | Lucey et al. | Apr 1997 | A |
5623336 | Raab et al. | Apr 1997 | A |
5635830 | Itoh | Jun 1997 | A |
5649924 | Everett et al. | Jul 1997 | A |
5697373 | Richards-Kortum et al. | Dec 1997 | A |
5698397 | Zarling et al. | Dec 1997 | A |
5710630 | Essenpreis et al. | Jan 1998 | A |
5716324 | Toida | Feb 1998 | A |
5719399 | Alfano et al. | Feb 1998 | A |
5730731 | Mollenauer et al. | Mar 1998 | A |
5735276 | Lemelson | Apr 1998 | A |
5740808 | Panescu et al. | Apr 1998 | A |
5748318 | Maris et al. | May 1998 | A |
5748598 | Swanson et al. | May 1998 | A |
5784352 | Swanson et al. | Jul 1998 | A |
5785651 | Kuhn et al. | Jul 1998 | A |
5795295 | Hellmuth et al. | Aug 1998 | A |
5801826 | Williams | Sep 1998 | A |
5803082 | Stapleton et al. | Sep 1998 | A |
5807261 | Benaron et al. | Sep 1998 | A |
5817144 | Gregory | Oct 1998 | A |
5840023 | Oraevsky et al. | Nov 1998 | A |
5840075 | Mueller et al. | Nov 1998 | A |
5842995 | Mahadevan-Jansen et al. | Dec 1998 | A |
5843000 | Nishioka et al. | Dec 1998 | A |
5843052 | Benja-Athon | Dec 1998 | A |
5847827 | Fercher | Dec 1998 | A |
5862273 | Pelletier | Jan 1999 | A |
5865754 | Sevick-Muraca et al. | Feb 1999 | A |
5867268 | Gelikonov et al. | Feb 1999 | A |
5871449 | Brown | Feb 1999 | A |
5872879 | Hamm | Feb 1999 | A |
5877856 | Fercher | Mar 1999 | A |
5887009 | Mandella et al. | Mar 1999 | A |
5892583 | Li | Apr 1999 | A |
5910839 | Erskine et al. | Jun 1999 | A |
5912764 | Togino | Jun 1999 | A |
5920373 | Bille | Jul 1999 | A |
5920390 | Farahi et al. | Jul 1999 | A |
5921926 | Rolland et al. | Jul 1999 | A |
5926592 | Harris et al. | Jul 1999 | A |
5949929 | Hamm | Sep 1999 | A |
5951482 | Winston et al. | Sep 1999 | A |
5955737 | Hallidy et al. | Sep 1999 | A |
5956355 | Swanson et al. | Sep 1999 | A |
5968064 | Selmon et al. | Oct 1999 | A |
5975697 | Podoleanu et al. | Nov 1999 | A |
5983125 | Alfano et al. | Nov 1999 | A |
5987346 | Benaron et al. | Nov 1999 | A |
5991697 | Nelson et al. | Nov 1999 | A |
5994690 | Kulkarni et al. | Nov 1999 | A |
6002480 | Izatt et al. | Dec 1999 | A |
6004314 | Wei et al. | Dec 1999 | A |
6006128 | Izatt et al. | Dec 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6014214 | Li | Jan 2000 | A |
6020963 | DiMarzio et al. | Feb 2000 | A |
6033721 | Nassuphis | Mar 2000 | A |
6044288 | Wake et al. | Mar 2000 | A |
6045511 | Ott et al. | Apr 2000 | A |
6048742 | Weyburne et al. | Apr 2000 | A |
6053613 | Wei et al. | Apr 2000 | A |
6069698 | Ozawa et al. | May 2000 | A |
6091496 | Hill | Jul 2000 | A |
6091984 | Perelman et al. | Jul 2000 | A |
6111645 | Tearney et al. | Aug 2000 | A |
6117128 | Gregory | Sep 2000 | A |
6120516 | Selmon et al. | Sep 2000 | A |
6134003 | Tearney et al. | Oct 2000 | A |
6134010 | Zavislan | Oct 2000 | A |
6134033 | Bergano et al. | Oct 2000 | A |
6141577 | Rolland et al. | Oct 2000 | A |
6151522 | Alfano et al. | Nov 2000 | A |
6159445 | Klaveness et al. | Dec 2000 | A |
6160826 | Swanson et al. | Dec 2000 | A |
6161031 | Hochman et al. | Dec 2000 | A |
6166373 | Mao | Dec 2000 | A |
6174291 | McMahon et al. | Jan 2001 | B1 |
6175669 | Colston et al. | Jan 2001 | B1 |
6185271 | Kinsinger | Feb 2001 | B1 |
6191862 | Swanson et al. | Feb 2001 | B1 |
6193676 | Winston et al. | Feb 2001 | B1 |
6198956 | Dunne | Mar 2001 | B1 |
6201989 | Whitehead et al. | Mar 2001 | B1 |
6208415 | De Boer et al. | Mar 2001 | B1 |
6208887 | Clarke | Mar 2001 | B1 |
6245026 | Campbell et al. | Jun 2001 | B1 |
6249349 | Lauer | Jun 2001 | B1 |
6263234 | Engelhardt et al. | Jul 2001 | B1 |
6264610 | Zhu | Jul 2001 | B1 |
6272376 | Marcu et al. | Aug 2001 | B1 |
6274871 | Dukor et al. | Aug 2001 | B1 |
6282011 | Tearney et al. | Aug 2001 | B1 |
6297018 | French et al. | Oct 2001 | B1 |
6308092 | Hoyns | Oct 2001 | B1 |
6324419 | Guzelsu et al. | Nov 2001 | B1 |
6341036 | Tearney et al. | Jan 2002 | B1 |
6353693 | Kano et al. | Mar 2002 | B1 |
6359692 | Groot | Mar 2002 | B1 |
6374128 | Toida et al. | Apr 2002 | B1 |
6377349 | Fercher | Apr 2002 | B1 |
6384915 | Everett et al. | May 2002 | B1 |
6393312 | Hoyns | May 2002 | B1 |
6394964 | Sievert, Jr. et al. | May 2002 | B1 |
6396941 | Bacus et al. | May 2002 | B1 |
6421164 | Tearney et al. | Jul 2002 | B2 |
6445485 | Frigo et al. | Sep 2002 | B1 |
6445944 | Ostrovsky | Sep 2002 | B1 |
6459487 | Chen et al. | Oct 2002 | B1 |
6463313 | Winston et al. | Oct 2002 | B1 |
6469846 | Ebizuka et al. | Oct 2002 | B2 |
6475159 | Casscells et al. | Nov 2002 | B1 |
6475210 | Phelps et al. | Nov 2002 | B1 |
6477403 | Eguchi et al. | Nov 2002 | B1 |
6485413 | Boppart et al. | Nov 2002 | B1 |
6485482 | Belef | Nov 2002 | B1 |
6501551 | Tearney et al. | Dec 2002 | B1 |
6501878 | Hughes et al. | Dec 2002 | B2 |
6538817 | Farmer et al. | Mar 2003 | B1 |
6549801 | Chen et al. | Apr 2003 | B1 |
6552796 | Magnin et al. | Apr 2003 | B2 |
6556305 | Aziz et al. | Apr 2003 | B1 |
6556853 | Cabib et al. | Apr 2003 | B1 |
6558324 | Von Behren et al. | May 2003 | B1 |
6564087 | Pitris et al. | May 2003 | B1 |
6564089 | Izatt et al. | May 2003 | B2 |
6567585 | Harris | May 2003 | B2 |
6615071 | Casscells, III et al. | Sep 2003 | B1 |
6622732 | Constantz | Sep 2003 | B2 |
6680780 | Fee | Jan 2004 | B1 |
6685885 | Varma et al. | Feb 2004 | B2 |
6687007 | Meigs | Feb 2004 | B1 |
6687010 | Horii et al. | Feb 2004 | B1 |
6687036 | Riza | Feb 2004 | B2 |
6701181 | Tang et al. | Mar 2004 | B2 |
6738144 | Dogariu et al. | May 2004 | B1 |
6741355 | Drabarek | May 2004 | B2 |
6790175 | Furusawa et al. | Sep 2004 | B1 |
6806963 | Wälti et al. | Oct 2004 | B1 |
6816743 | Moreno et al. | Nov 2004 | B2 |
6839496 | Mills et al. | Jan 2005 | B1 |
6903820 | Wang | Jun 2005 | B2 |
6949072 | Furnish et al. | Sep 2005 | B2 |
6980299 | de Boer | Dec 2005 | B1 |
7006231 | Ostrovsky et al. | Feb 2006 | B2 |
7019838 | Izatt et al. | Mar 2006 | B2 |
7061622 | Rollins et al. | Jun 2006 | B2 |
7190464 | Alphonse | Mar 2007 | B2 |
7231243 | Tearney et al. | Jul 2007 | B2 |
7242480 | Alphonse | Jul 2007 | B2 |
7267494 | Deng et al. | Sep 2007 | B2 |
7336366 | Choma et al. | Feb 2008 | B2 |
7355716 | De Boer et al. | Apr 2008 | B2 |
7359062 | Chen et al. | Apr 2008 | B2 |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7391520 | Zhou et al. | Jun 2008 | B2 |
20010047137 | Moreno et al. | Nov 2001 | A1 |
20020016533 | Marchitto et al. | Feb 2002 | A1 |
20020052547 | Toida | May 2002 | A1 |
20020064341 | Fauver et al. | May 2002 | A1 |
20020076152 | Hughes et al. | Jun 2002 | A1 |
20020085209 | Mittleman et al. | Jul 2002 | A1 |
20020093662 | Chen et al. | Jul 2002 | A1 |
20020122246 | Tearney et al. | Sep 2002 | A1 |
20020140942 | Fee et al. | Oct 2002 | A1 |
20020158211 | Gillispie | Oct 2002 | A1 |
20020161357 | Anderson et al. | Oct 2002 | A1 |
20020163622 | Magnin et al. | Nov 2002 | A1 |
20020172485 | Keaton et al. | Nov 2002 | A1 |
20020183623 | Tang et al. | Dec 2002 | A1 |
20020188204 | McNamara et al. | Dec 2002 | A1 |
20020196446 | Roth et al. | Dec 2002 | A1 |
20020198457 | Tearney et al. | Dec 2002 | A1 |
20030023153 | Izatt et al. | Jan 2003 | A1 |
20030026735 | Nolte et al. | Feb 2003 | A1 |
20030082105 | Fischman et al. | May 2003 | A1 |
20030108911 | Klimant et al. | Jun 2003 | A1 |
20030135101 | Webler | Jul 2003 | A1 |
20030164952 | Deichmann et al. | Sep 2003 | A1 |
20030171691 | Casscells, III et al. | Sep 2003 | A1 |
20030174339 | Feldchtein et al. | Sep 2003 | A1 |
20030199769 | Podoleanu et al. | Oct 2003 | A1 |
20030216719 | Debenedictis et al. | Nov 2003 | A1 |
20030220749 | Chen et al. | Nov 2003 | A1 |
20030236443 | Cespedes et al. | Dec 2003 | A1 |
20040002650 | Mandrusov et al. | Jan 2004 | A1 |
20040086245 | Farroni et al. | May 2004 | A1 |
20040100631 | Bashkansky et al. | May 2004 | A1 |
20040100681 | Bjarklev et al. | May 2004 | A1 |
20040126048 | Dave et al. | Jul 2004 | A1 |
20040133191 | Momiuchi et al. | Jul 2004 | A1 |
20040150829 | Koch et al. | Aug 2004 | A1 |
20040152989 | Puttappa et al. | Aug 2004 | A1 |
20040166593 | Nolte et al. | Aug 2004 | A1 |
20040212808 | Okawa et al. | Oct 2004 | A1 |
20040239938 | Izatt | Dec 2004 | A1 |
20050018133 | Huang et al. | Jan 2005 | A1 |
20050018201 | De Boer | Jan 2005 | A1 |
20050046837 | Izumi et al. | Mar 2005 | A1 |
20050075547 | Wang | Apr 2005 | A1 |
20050083534 | Riza et al. | Apr 2005 | A1 |
20050165303 | Kleen et al. | Jul 2005 | A1 |
20050171438 | Chen et al. | Aug 2005 | A1 |
20060103850 | Alphonse et al. | May 2006 | A1 |
20060155193 | Leonardi et al. | Jul 2006 | A1 |
20060244973 | Yun et al. | Nov 2006 | A1 |
20070019208 | Toida et al. | Jan 2007 | A1 |
20070291277 | Everett et al. | Dec 2007 | A1 |
Number | Date | Country |
---|---|---|
4105221 | Sep 1991 | DE |
4309056 | Sep 1994 | DE |
19542955 | May 1997 | DE |
10351319 | Jun 2005 | DE |
0110201 | Jun 1984 | EP |
0251062 | Jan 1988 | EP |
0617286 | Feb 1994 | EP |
0590268 | Apr 1994 | EP |
0728440 | Aug 1996 | EP |
0933096 | Aug 1999 | EP |
1324051 | Jul 2003 | EP |
1426799 | Jun 2004 | EP |
2738343 | Aug 1995 | FR |
1257778 | Dec 1971 | GB |
2030313 | Apr 1980 | GB |
2209221 | May 1989 | GB |
2298054 | Aug 1996 | GB |
6073405 | Apr 1985 | JP |
4135550 | May 1992 | JP |
4135551 | May 1992 | JP |
5509417 | Nov 1993 | JP |
7900841 | Oct 1979 | WO |
9201966 | Feb 1992 | WO |
9216865 | Oct 1992 | WO |
9219930 | Nov 1992 | WO |
9303672 | Mar 1993 | WO |
9533971 | Dec 1995 | WO |
9628212 | Sep 1996 | WO |
9732182 | Sep 1997 | WO |
9800057 | Jan 1998 | WO |
9801074 | Jan 1998 | WO |
9814132 | Apr 1998 | WO |
9835203 | Aug 1998 | WO |
9838907 | Sep 1998 | WO |
9846123 | Oct 1998 | WO |
9848838 | Nov 1998 | WO |
9848846 | Nov 1998 | WO |
9905487 | Feb 1999 | WO |
9944089 | Sep 1999 | WO |
9957507 | Nov 1999 | WO |
0058766 | Oct 2000 | WO |
0108579 | Feb 2001 | WO |
0127679 | Apr 2001 | WO |
0138820 | May 2001 | WO |
0142735 | Jun 2001 | WO |
0236015 | May 2002 | WO |
0238040 | May 2002 | WO |
02054027 | Jul 2002 | WO |
03020119 | Mar 2003 | WO |
03046636 | Jun 2003 | WO |
03052478 | Jun 2003 | WO |
03062802 | Jul 2003 | WO |
03105678 | Dec 2003 | WO |
2004034869 | Apr 2004 | WO |
2004057266 | Jul 2004 | WO |
2004066824 | Aug 2004 | WO |
2004088361 | Oct 2004 | WO |
2004015598 | Dec 2004 | WO |
2005000115 | Jan 2005 | WO |
2005047813 | May 2005 | WO |
2005054780 | Jun 2005 | WO |
2005082225 | Sep 2005 | WO |
2006004743 | Jan 2006 | WO |
2006014392 | Feb 2006 | WO |
2006039091 | Apr 2006 | WO |
2006059109 | Jun 2006 | WO |
2006124860 | Nov 2006 | WO |
2006130797 | Dec 2006 | WO |
2007028531 | Mar 2007 | WO |
2007038787 | Apr 2007 | WO |
2007083138 | Jul 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20070263227 A1 | Nov 2007 | US |
Number | Date | Country | |
---|---|---|---|
60800088 | May 2006 | US |